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Abstract
Triton X-100 inhibits the NADH oxidase and rotenone-sensitive NADH-Q1 reductase activities of bovine heart
submitochondrial particles (SMP) with an apparent Ki of 1U1035 M (pH 8.0, 25‡C). The NADH-hexammineruthenium
reductase, succinate oxidase, and the respiratory control ratio with succinate as the substrate in tightly coupled SMP are not
affected at the inhibitor concentrations below 0.15 mM. The succinate-supported aerobic reverse electron transfer is less
sensitive to the inhibitor (Ki = 5U1035 M) than NADH oxidase. Similar to rotenone, limited concentrations of Triton X-100
increase the steady-state level of NAD reduction when the nucleotide is added to tightly coupled SMP oxidizing succinate
aerobically. Also similar to rotenone, Triton X-100 partially protects Complex I against the thermally induced deactivation
and partially activates the thermally deactivated enzyme. The rate of the NADH oxidase inhibition by rotenone is drastically
decreased in the presence of Triton X-100 which indicates a competition between these two inhibitors for a common specific
binding site. In contrast to rotenone, the inhibitory effect of Triton X-100 is instantly reversed upon dilution of the reaction
mixture. The NADH-Q1 reductase activity of SMP is inhibited non-competitively by added Q1 whereas a simple competition
between Q1 and the inhibitor is seen for isolated Complex I. The results obtained show that Triton X-100 is a specific
inhibitor of the ubiquinone reduction by Complex I and are in accord with our previous findings which suggest that different
reaction pathways operate in the forward and reverse electron transfer at this segment of the mammalian respiratory
chain. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Little is known about the mechanism by which the
respiratory chain-linked type 1 NADH dehydrogen-
ases (Complex I, EC 1.6.5.3) reduce endogenous bulk
quinone acceptor. Neither the sequence of intramo-
lecular electron transfer among the multiple redox
components, nor the number of the substrate binding
sites, or the mechanism of the redox-linked vectorial
0005-2728 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
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Abbreviations: SMP, submitochondrial particles ; FMN, £avin
mononucleotide; CMC, critical micelle formation concentration;
ANS, 8-aniline naphthalene sulfonate; BSA, bovine serum albu-
min; Q, natural ubiquinone-10; Q1, homolog of ubiquinone hav-
ing 1 isoprenoid unit in position 6 of the quinone ring; MPP,
1-methyl-4-phenylpyridinium
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proton translocation by this gigantic energy trans-
ducer are known.
The mammalian enzyme (the classical object for
numerous studies) is exceptionally complex. It com-
prises more than 40 di¡erent subunits [1] and con-
tains at least eight distinct redox components (FMN,
5^6 EPR detectable iron-sulfur clusters, at least two
bound ubiquinone species) [2]. Among technical dif-
¢culties which hamper progress of the ¢eld, the lack
of pure soluble (optically transparent) enzyme prep-
aration showing activity identical to that observed in
situ within the intact inner mitochondrial membrane
does not seem to be the least. The only puri¢ed
preparation which catalyzes rapid rotenone-sensitive
reduction of ubiquinone is so-called Complex I ^ a
lipoprotein enzyme isolated from bovine heart mito-
chondria using bile salts for solubilization [3]. The
preparation is insoluble in the absence of detergents
and contains a number of impurities (transhydroge-
nase, b-c1 complex, subunits of cytochrome oxidase)
[3,4]. A number of other preparations (so-called type
1 soluble high-molecular-mass NADH dehydrogen-
ases) are similar to Complex I in their composition
and prosthetic groups and subunits but lack the ro-
tenone-sensitive ubiquinone reductase activity [5^9].
Recently, a new chromatographic procedure for the
isolation of NADH-ubiquinone reductase from do-
decyl maltoside solubilized mitochondria has been
developed [10]. The enzyme is devoid of phospholip-
ids and contains all 43 subunits found in Complex
I. The speci¢c rotenone-sensitive activity of the ho-
mogeneous monodispersed enzyme in the NADH-
decyl ubiquinone assay in the presence of phospha-
tidylcholine at 30‡C was reported as 1.2 Wmol of
NADH oxidized per min per mg of protein [10]
which is about the same as the speci¢c activity of
submitochondrial particles in the uncoupled state
[11]. An alternative procedure for the enzyme puri¢-
cation thus seems obviously needed.
There have been several reports in the literature on
the attempts to solubilize the respiratory chain-linked
NADH dehydrogenase using the ‘mild’ non-ionic de-
tergent Triton X-100. Strong inhibition of the
NADH oxidase and NADH-ubiquinone reductase
activities of the bovine heart electron-transporting
particles (ETP) by Triton X-100 (1.6U1034%, i.e.
V3U1036 M for 50% inhibition) was noted when
the detergent has been applied for the enzyme solu-
bilization [12]. The inhibition was claimed to be par-
tially reversed by washing the particles with 2% se-
rum albumin but not by dilution. The detergent had
no e¡ect on the NADH-ferricyanide reductase activ-
ity even at 1% concentration. Judging by the speci¢c
activity of the solubilized protein in the ferricyanide
assay the author has concluded that use of Triton X-
100 o¡ers no advantage over other methods of type 1
NADH dehydrogenase extraction [12]. On the other
hand, the puri¢cation of the Triton X-100 solubilized
phospholipid-free type 1 dehydrogenase capable of
rapid rotenone-sensitive reduction of ubiquinone
(the speci¢c activity of 59 Wmol of NADH oxidized
per min per mg at 22‡C) and reconstitution of the
antimycin A-sensitive NADH-cytochrome c reduc-
tase has been reported by Baugh and King [13]. Re-
moval of the strongly inhibitory detergent from the
solubilized dehydrogenase was claimed as the key to
the success of the reconstitution [13]. The results of
Baugh and King have not been con¢rmed independ-
ently; moreover, Ragan claimed that he has been
unable to measure rotenone-sensitive reaction cata-
lyzed by the preparations of this enzyme [14].
Unfortunately, no isolation method of the highly
active rotenone-sensitive NADH-ubiquinone oxido-
reductase has been developed so far other than clas-
sical Hate¢’s procedure [3]. It is expected that di¡er-
ent puri¢cation methods would be bene¢cial for
further studies of the enzyme structure and mecha-
nism. During our continuous attempts to approach
this goal, we con¢rmed the original observations
[12,13] on the strong inhibitory e¡ect of Triton X-
100 on NADH oxidation by submitochondrial par-
ticles. Several features of this inhibition seemed to
merit closer examination because of its apparent im-
portance for both mechanistic studies and for further
development of new preparative procedures. In this
report we will describe the essential parameters of the
speci¢c inhibitory e¡ect of Triton X-100 on the bo-
vine heart NADH-ubiquinone oxidoreductase. The
preliminary account of this work has been published
elsewhere [15].
2. Materials and methods
Coupled submitochondrial particles (SMP) [16]
and bovine heart Complex I [3] were prepared ac-
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cording to the published procedures. Protein content
was determined with biuret reagent. The enzymatic
activities were assayed at 25‡C in the standard reac-
tion mixture containing 0.25 M sucrose, 50 mM Tris-
Cl3, 0.2 mM EDTA (pH 8.0), bovine serum albumin
(1 mg/ml). Other additions and the details of the
experiments are described in the legends of Figs. 1^8.
All the ‘uncoupled’ activities were assayed in the
presence of gramicidin D (0.2 Wg/ml). Succinate oxi-
dase (10 mM potassium succinate as the substrate)
was measured by platinum electrode covered with
Te£on membrane. The NADH oxidase, NADH-Q1
reductase, NADH-hexammineruthenium reductase
[17] and the reverse electron transfer activities were
measured as the decrease (or increase when the re-
verse electron transfer was measured) in optical ab-
sorbance at 340 nm with 100 WM NADH or 1 mM
NAD or at 380 nm with 500 WM NADH as the
substrate. Rotenone- and uncoupler-sensitive succi-
nate-ferricyanide reductase (reverse electron transfer)
was measured in the presence of 10 mM succinate
and 100 WM ferricyanide as the decrease in absor-
bancy at 420 nm. All the catalytic assays, except
for those presented in Fig. 6, were conducted after
the addition and complete oxidation of 5 WM NADH
in order to activate the enzyme [16].
Triton X-100 critical micelle formation concentra-
tion (CMC) was determined from the sharp increase
of 10 WM 8-aniline naphthalene sulfonate (ANS) £u-
orescence (excitation at 370 nm, emission at 480 nm)
in the standard assay reaction mixture upon addition
of Triton X-100 [18]. The value of 0.23 mM was in
agreement with the data reported in the literature
[19^21].
Although the commercial samples of Triton X-100
are a mixture of 4-tert-octylphenyl polyoxyethylene
ethers containing on average 9.6 oxyethylene groups
[20,21], the amount of added compound is expressed
in molar concentrations throughout the paper (rather
than as percent or mg per mg of protein as is widely
used) assuming an average molecular weight of 625.
The same results were obtained with the preparations
of Triton X-100 obtained from Serva (Cat. No.
37240) or from Merck (Art. 11869). It is pertinent
to emphasize that the concentrations of added Triton
X-100 were always considerably lower than CMC
(except for the data shown in Fig. 1 where a wide
concentration range was used) so that true homo-
geneous solutions of the inhibitor are to be consid-
ered.
NADH, NAD, malonate, succinate, oligomycin,
gramicidin D, EDTA, antimycin A, bovine serum
albumin (BSA, fraction V) and rotenone were from
Sigma (USA); Tris (base) and Triton X-100 were
from Serva (Germany). Q1 was a kind gift from Ei-
sai, Japan. Other chemicals were of the highest qual-
ity commercially available. All calculations and curve
¢ttings were performed using the GIM Version 2
computer program (A. Drachevz).
3. Results
Fig. 1 shows the e¡ect of Triton X-100 on various
activities of SMP. Both uncoupled NADH oxidase
and the rotenone-sensitive NADH-Q1 reductase were
inhibited with apparent Ki in the micromolar range
Fig. 1. E¡ect of Triton X-100 on various activities of submito-
chondrial particles. (b) Uncoupled NADH oxidase (50 Wg SMP
per ml); (a) uncoupled NADH-Q1 reductase (50 Wg SMP per
ml, 40 WM Q1 and 1 Wg antimycin A per ml were added to the
standard assay mixture); (R) uncoupled succinate oxidase (0.25
mg SMP per ml, 10 mM potassium succinate were added); (O)
respiratory control ratio measured as a ratio of the respiratory
activities with 10 mM succinate as the substrate in the presence
and absence of 0.2 Wg of gramicidin D per ml; (F) NADH-hex-
ammineruthenium (III) reductase (13 Wg of SMP per ml, 500
WM NADH, 2 mM hexammineruthenium (III) and 5 mM
NaN3 were added to the assay mixture). The speci¢c activities
of uncoupled SMP were: 1.3 (NADH oxidase), 0.4 (NADH-Q1
reductase), 10.6 (NADH-hexammineruthenium reductase) and
0.45 (succinate oxidase) Wmol of the substrate oxidized per min
per mg of protein.
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whereas neither uncoupled and coupled succinate ox-
idase nor respiratory control ratio with succinate as
the substrate, nor NADH-hexammineruthenium (III)
reductase activity were signi¢cantly a¡ected up to a
concentration of Triton X-100 of 150 WM. The in-
hibition of the uncoupled succinate oxidase at high
Triton X-100 concentration was most likely due to
the detergent e¡ect upon the mitochondrial mem-
brane as was evidenced by a coincidence of the crit-
ical micellization concentration (see Section 2) and
the abrupt appearance of the inhibitory e¡ect which
was seen above CMC. Indeed, the inhibited un-
coupled succinate oxidase activity at 250 WM Triton
X-100 was almost completely restored by the addi-
tion of cytochrome c (results not shown). In all fur-
ther experiments the concentration of Triton X-100
never exceeded its characteristic CMC.
The inhibitory e¡ect of Triton X-100 upon the
NADH-ubiquinone reductase region of the respira-
tory chain was found to be completely and rapidly
reversible as is illustrated in Fig. 2. When NADH
oxidase was decreased by the addition of 24 WM
Triton X-100 (30% of original activity remained)
the respiration was restored up to 80% simply by
10 times dilution of the reaction mixture as is ex-
pected for the rapidly reversible inhibition. In sepa-
rate experiments it was shown that the apparent Ki
for Triton X-100 was independent of the protein/in-
hibitor ratio within the protein content in the assay
mixture of 12^120 Wg/ml.
The results shown in Fig. 1 are consistent with the
notion that the inhibitory e¡ect of Triton X-100 is
directed to the ubiquinone junction site of NADH
oxidase [12,13]. Rotenone ^ the speci¢c inhibitor of
the mammalian Complex I ^ is widely used as a
diagnostic tool for dissection of that region of the
respiratory chain [22^25]. It seemed of interest to
obtain a closer insight into mutual relationship be-
tween the inhibitory e¡ects of rotenone and Triton
X-100. The results presented in Fig. 3 show that
Triton X-100 strongly decreases the rate of the en-
zyme-rotenone interaction (A) and increases the ap-
parent Ki for rotenone under equilibrium conditions
(B). This behavior is expected if rotenone and Triton
X-100 compete for the common binding site.
A great variety of compounds with di¡erent de-
grees of chemical complexity speci¢cally inhibiting
the ubiquinone reductase site(s) of the respiratory
chain-linked NADH dehydrogenase have been de-
scribed [26^28]. The classical high a⁄nity inhibitors
rotenone [22^25] and piericidin A [29] are thought to
be bound at or close to the quinone binding site(s)
[30]. We have recently pointed out that the kinetic
type of inhibition as related to the added quinone
acceptor for the tightly bound inhibitors is di⁄cult
if not impossible to determine because of very slow
equilibration between the enzyme and inhibitor [25].
Since Triton X-100 rapidly equilibrates with the en-
zyme (Fig. 2) and competes with rotenone, it was of
obvious interest to study the kinetic pattern of the
inhibition. Two preparations were used: SMP which
contain endogenous bulk ubiquinone and puri¢ed
Complex I which presumably contains only tightly
bound ubiquinone. In accord with the numerous
Fig. 2. Reversal of the inhibitory e¡ect of Triton X-100 by dilu-
tion. (A) SMP (16 Wg per ml) were activated by the addition
and complete oxidation of 5 WM NADH. The reaction was
started by the addition of 100 WM NADH (where indicated).
24 WM Triton X-100 was added and 0.2 ml of the mixture were
transferred (indicated by thick arrow) to another 1.8 ml assay
cuvette containing 150 WM NADH and no Triton X-100 (B).
The sensitivity of the instrument in (B) was increased 10 times.
The ¢gures on the traces are the speci¢c activities (Wmol of
NADH oxidized per min per mg of protein).
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data published in the literature our preparations of
SMP and Complex I contain 5^6 and 3^4 nmol of
ubiquinone per mg of protein, respectively (unpub-
lished results from our laboratory). These values cor-
respond to more than 50 times molar excess of qui-
none over Complex I content in SMP and to about
3(4):1 stoichiometry of bound Q:FMN in the puri-
¢ed Complex I. The kinetics of inhibition by Triton
X-100 were found to be di¡erent for these prepara-
tions. Pure competitive inhibition was evident for
puri¢ed Complex I whereas essentially non-compet-
itive inhibition was found for SMP (Figs. 4 and 5).
For comparison, the kinetics of another Complex I
inhibitor capsaicin [31,32] were determined under the
same assay conditions and qualitatively the same
patterns for either enzyme preparation were found.
The simplest explanation for the ¢ndings depicted in
Figs. 4 and 5 is that both Triton X-100 and capsaicin
compete with quinone acceptor. When puri¢ed Com-
plex I reacts with added Q1 the latter binds to the
speci¢c quinone binding site(s) and the inhibitors
prevent this binding. When membrane-bound Com-
plex I operates in the presence of the substantial
amount of the endogenous ubiquinone the overall
reaction occurs mainly through reoxidation of bulk
endogenous ubiquinol by the externally added Q1.
The competitive inhibition of the endogenous ubiqui-
none reduction by either capsaicin or Triton X-100
in this case would be equivalent to a decrease of the
total enzyme concentration (signi¢cant decrease of V
with no change of the apparent KQ1m ). It should be
mentioned that straightforward interpretation of the
kinetics of the externally added water soluble qui-
nones interaction with the membrane-bound enzymes
is far from simple [32,33]. We o¡er an explanation
for the data shown in Figs. 4 and 5 just as the sim-
plest hypothesis.
When the kinetic pattern of the NADH oxidase
Fig. 3. E¡ect of Triton X-100 on NADH oxidase inhibition by rotenone. (A) SMP (50 Wg/ml), activated by oxidation of 5 WM
NADH, were incubated in the standard reaction mixture containing no albumin with 20 nM rotenone for the time intervals indicated
on the abscissa. The samples were added to the assay mixture (10 times dilution) and the residual activities were measured (b). 24 WM
Triton X-100 was added before rotenone to the incubation mixture (a). 100% corresponds to the speci¢c activity of 0.8 Wmol/min/mg.
(B) (b) SMP (5 mg/ml) were activated by aerobic preincubation with 1 mM NADPH at 20‡C for 30 min. The suspension was diluted
10 times with the standard reaction mixture containing no bovine serum albumin and residual deactivated enzyme (about 35%) was ir-
reversibly inactivated by 1 mM N-ethylmaleimide [47]. Rotenone was added (¢nal concentrations are indicated on the abscissa) to the
samples thus treated and the mixtures were further incubated for 1 h at 6‡C (no deactivation occurs at this temperature [16]). (a) 200
WM Triton X-100 was added to the samples before rotenone. The NADH oxidase activities were assayed (5 Wg/ml) in the standard
mixture containing no albumin. 100% corresponds to the speci¢c activities 0.5 and 0.35 Wmol of NADH oxidized per min per mg of
protein for the curves (b) and (a), respectively. Lower activity of the samples incubated in the presence of Triton X-100 was due to
the small amount of the residual Triton X-100 transferred with the protein to the assay mixture (2 WM). The intercept of the titration
curve 1 with the abscissa corresponds to the amount of active enzyme in SMP of 0.1 nmol/mg of protein.
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Fig. 4. Kinetics of the NADH-Q1 reductase activity of puri¢ed Complex I in the presence of Triton X-100 (A) and dihydrocapsaicin
(B). Complex I (1 mg/ml) was suspended in the standard medium containing sonicated asolectin (1 mg/ml). The protein content in the
assay mixture was 5 Wg/ml. The enzyme preparation was activated by the complete oxidation of 5 WM NADH prior assay. Antimycin
A (1 Wg/ml) was added to the standard assay mixture. The catalytic activities were measured at 37‡C. Figures on the lines indicate
concentrations of the inhibitors added (WM). The catalytic activities were expressed as Wmol of NADH oxidized per min per mg of
protein. No albumin was present in the reaction mixture in (B).
Fig. 5. Kinetics of the NADH-Q1 reductase activity of SMP in the presence of Triton X-100 (A) and dihydrocapsaicin (B). The pro-
tein content in the assay mixture was 25 Wg/ml. The enzyme preparation was activated by the complete oxidation of 5 WM NADH
prior assay. Antimycin A (1 Wg/ml) was added to the standard assay mixture. The catalytic activities were measured at 37‡C. Figures
on the lines indicate concentrations of the inhibitors added (WM). The catalytic activities were expressed as Wmol of NADH oxidized
per min per mg of protein. No albumin was present in the reaction mixture in (B).
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inhibition by Triton X-100 was studied at di¡erent
NADH concentrations the simple non-competitive
inhibition (decrease of V with no change of KNADHm
(5 WM)) was found (results not shown). This ¢nding
agrees with the absence of the inhibitory e¡ect of
Triton X-100 on NADH-hexammineruthenium (III)
reductase, i.e. on the primary dehydrogenating reac-
tion (Fig. 1).
We have previously shown that the speci¢c Q-
junction site-directed inhibitor rotenone partially
prevents and reverses the thermally induced deacti-
vation of the membrane-bound Complex I [25]. Since
all the data presented above suggest that Triton X-
100 inhibits at the same site(s) as rotenone does, it
was of interest to ¢nd out whether Triton X-100
a¡ects the enzyme slow active/inactive transition.
Fig. 6 shows the e¡ects of Triton X-100 and rote-
none on the spontaneous thermally induced transfor-
mation. Similar to rotenone, Triton X-100 was able
to protect the enzyme and to activate it when added
after deactivation. However, quantitatively both pro-
tective and activating e¡ect of Triton X-100 were
signi¢cantly less than that of rotenone.
The characteristic feature of rotenone as the inhib-
itor is that the forward reaction (NADH oxidation)
is much more sensitive to the inhibitor than the re-
verse reaction (vWH-dependent NAD reduction)
[25,34]. Qualitatively the same phenomenology was
found for the inhibitory e¡ect of Triton X-100
(Fig. 7). The apparent Ki values for NADH oxidase
and aerobic succinate supported NAD reduction
were 10 and 50 WM, respectively. The inhibition pat-
tern was characteristic for a simple hyperbolic de-
crease of either activities within the inhibitor concen-
tration range up to 100 WM. At higher concentration
of Triton X-100 the upward deviation from the
straight line on the reciprocal rate versus the inhib-
itor concentration graphs was observed for the re-
verse electron transfer (Fig. 7A, insert). This devia-
tion was most likely due to the uncoupling e¡ect of
Triton X-100 when its concentration approached the
point where the micellization starts. The di¡erence in
the sensitivities of the forward and reverse reaction
was also evident from the e¡ect of Triton X-100 on
the steady-state level of NAD reduction during
aerobic succinate oxidation by the coupled particles
in the presence of NAD (Fig. 8). A limited concen-
tration of Triton X-100 (32 WM) required to inhibit
the NADH oxidase activity and the reverse electron
transfer by about 80% and 40%, respectively (see the
titration curves in Fig. 7) increases the steady-state
level of NAD reduction.
4. Discussion
In order to study the structure and mechanism of
the enzyme it is desirable to learn how the detergent
applied for solubilization interacts (speci¢cally or un-
speci¢cally) with the protein. Although the inhibitory
e¡ect of Triton X-100 on NADH-quinone reductase
region of the mammalian respiratory chain was occa-
sionally claimed [12,13,35,36], to our knowledge no
detailed studies on this phenomenon have been re-
ported. On the other hand, Triton X-100 has been
used as a non-ionic, nondenaturing detergent for sol-
ubilization of a number of the membrane-bound en-
zymes including mitochondrial NADH-quinone re-
Fig. 6. Protecting and reactivating e¡ects of Triton X-100 and
rotenone on the thermally induced deactivation of Complex I
in SMP. NADPH-activated SMP, prepared as described [48]
(3.5 mg/ml) were deactivated by incubation for 2 h at 30‡C and
the initial rates of the uncoupler and rotenone-sensitive succi-
nate-ferricyanide reductase (reverse electron transfer) were
measured before (1) and after (2) deactivation. 1 WM rotenone
(3) or 100 WM Triton X-100 (5) were added before the thermal
treatment. Rotenone (4) or Triton X-100 (6) were added to the
deactivated particles and the reverse electron transfer was as-
sayed after incubation for 1 h at 30‡C. All the activities were
measured after the protein samples withdrawn were preincu-
bated in the assay mixture containing albumin for 5 min to
bind free rotenone [25].
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ductases from bovine heart [12,13], Solanum tuber-
osum [37] and Neurospora crassa [38].
Our data con¢rm and signi¢cantly extend the orig-
inal observations [12,13,35,36] on strong inhibition
of NADH-ubiquinone reductase by the substituted
phenol-polyoxyethylene ethers. As documented in
this paper Triton X-100 is a speci¢c inhibitor of
Complex I. Our ¢nding is in accord with the data
of Bataynen et al. who concluded many years ago
that several long chain alkyl compounds (alcohols,
amines, free fatty acids and their methyl esters, de-
oxycholate, dodecyl sulfate) impair NADH oxidase
by a speci¢c perturbation of Complex I [39]. This
conclusion was recently con¢rmed by Okun et al.
who suggested that the e¡ect of various detergents
on Complex I is due to direct competition for the
binding site and not delipidation of the complex
[40]. The inhibitory potency of Triton X-100
(Ki = 1035 M) is in the range of that for a number
of other inhibitors which are considered to be speci¢c
for coupling site I such as capsaicin [31,32] and its
synthetic derivatives [41], 1-methyl-4-phenylpyridi-
nium (MPP) and its analogs [42,43] or 2-alkyl-4,6-
dinitrophenols [44]. The apparent quantitative incon-
sistencies of our results with those claimed by Gut-
man [12] on the inhibitor a⁄nity and only partial
removal of Triton X-100 inhibition by washing
with serum albumin are hard to discuss because nei-
ther the conditions for the inhibition experiments
Fig. 8. Stimulating e¡ect of Triton X-100 on the aerobic succi-
nate-supported NAD reduction (reverse electron transfer).
SMP (50 Wg/ml) were pulsed with 5 WM NADH and the reac-
tion was started by the simultaneous addition of succinate (10
mM) and NAD (1 mM). 32 WM Triton X-100 was added
where indicated.
Fig. 7. Inhibitory e¡ect of Triton X-100 on the forward [NADH oxidase (b)] and reverse [succinate-supported, uncoupler-sensitive
NAD reduction (a)] electron transfer reactions. Insert in panel A shows the reciprocal rate dependence on the Triton X-100 concen-
tration corresponding to curve (a). (B) The reciprocal rate dependence on Triton X-100 within the limited inhibitor concentrations
(below CMC). 100% corresponds to the activities of 1.3 and 0.12 Wmol/min/mg for NADH oxidase and reverse electron transfer, re-
spectively.
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(i.e. pH, temperature, the nature and concentrations
of the quinone-acceptor, protein content) nor Triton
X-100 samples used in their studies have been speci-
¢ed. On the other hand, our data (Fig. 1) are in
agreement with the absence of the inhibitory e¡ect
of Triton X-100 on the NADH-ferricyanide reduc-
tase activity previously reported [12]. Since Triton
X-100 competes with rotenone for the common (or
shared) binding site(s) (Fig. 3) and rotenone and
piericidin A are believed to bind at or close to the
ubiquinone binding site(s) [30], Triton X-100 seems
to be a useful compound to analyze the structural
and mechanistic features of the Complex I-associated
ubiquinone oxidoreduction. Rapidly equilibrating
Triton X-100 acts as a competitive inhibitor on Com-
plex I and as non-competitive inhibitor on SMP
(Figs. 4 and 5). The same kinetic patterns were
seen for the inhibition by capsaicin. The latter obser-
vation is in agreement with the results of Shimomura
et al. [31] for isolated Complex I (simple competitive
inhibition) and in contrast to the data of Yagi ob-
tained on Type-1 enzyme in Escherichia coli mem-
branes, bovine heart SMP and Paracoccus mem-
branes [32] and to the report of Satoh et al. on the
inhibitory e¡ect of one of the synthetic capsaicin
analogue (compound 37, Fig. 3 in [41]) with bovine
heart SMP as the enzyme preparation. Yagi [32] and
Satoh et al. [41] observed a curvilinear dependence
1/rate versus 1/quinone concentration in the presence
of capsaicin. In low quinone acceptor concentration
range, capsaicin acted as a non-competitive inhibitor
whereas a competitive inhibition was evident at high-
er concentrations of quinone. The reasons for this
apparent contradictions with our results remain ob-
scure. We believe that one possible explanation is
that the membrane-bound enzyme preparations
used by Yagi and Satoh et al. could be ‘kinetically’
heterogeneous, i.e. contained a mixture of active and
deactivated Complex I [11,16,45].
We have previously shown that rotenone binds
more strongly to the active ‘turnover pulsed’ enzyme
than to its deactivated form [25]. This appears to be
also true for Triton X-100 (Fig. 6). It is thus expected
that Triton X-100 solubilized Complex I would con-
tain inhibitory detergent molecule(s) bound at
Q-site(s) thus stabilizing the ubiquinone reactive state
of the enzyme. These prediction seems to be of im-
portance for the strategy of isolation and puri¢cation
of the ‘native’ rotenone-sensitive ubiquinone reactive
enzyme ^ a goal which remains to be reached.
The last point to be brie£y discussed concerns the
di¡erent sensitivity of forward and reverse electron
transfer to Triton X-100 (Fig. 7). Qualitatively the
same results have been obtained previously for rote-
none [25,34]. The di¡erence in the apparent Ki values
determined from the Triton X-100 titration curves
(Fig. 7) can be explained by a number of proposals
such as the possible e¡ect of energization on the
enzyme structure [34], the di¡erence in the ubiqui-
none reduction level during the steady-state NADH
oxidation or NAD reduction or, less likely, by the
possible heterogeneity of SMP. However, the stimu-
lating e¡ect of Triton X-100 on the aerobic succinate
supported NAD reduction seems hard to explain,
unless the model includes existence of di¡erent reac-
tion pathways for forward and reverse electron trans-
fer. Such stimulation was previously reported for ro-
tenone which also interacts at Q-site(s) and for
another hydrophilic competitive nucleotide-binding
site(s) interacting inhibitor ADP-ribose [46]. The
‘unidirectional’ preference of the inhibitory e¡ect of
Triton X-100 strengthens our proposal of di¡erent
binding sites for both pairs of the substrates
(NADH/NAD and ubiquinol/ubiquinone) which
operates in the forward and reverse electron transfer
catalyzed by the membrane-bound mammalian Com-
plex I [25,46].
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